Health-care expenditures are less for minimally invasive than open colectomy for colon cancer: A US commercial claims database analysis.

ABSTRACT:

Background

Most studies comparing surgical platforms focus on short-term outcomes. In this study, we compare the expanding societal penetration of minimally invasive surgery (MIS) with open colectomy by assessing payer and patient expenditures up to one year for patients undergoing surgery for colon cancer.

Methods

We analyzed the IBM MarketScan Database for patients who underwent left or right colectomy for colon cancer between 2013 and 2020. Outcomes included perioperative complications and total health-care expenditures up to 1 year following colectomy. We compared results for patients who had open colectomy (OS) to those with MIS operations. Subgroup analyses were performed for adjuvant chemotherapy (AC+) versus no adjuvant chemotherapy (AC-) groups and for laparoscopic

SUBMITTER: Bastawrous AL 

PROVIDER: S-EPMC10338385 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature